medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-11-92-99medsovet-1548Research ArticleСПАСТИЧЕСКИЕ РАССТРОЙСТВАSPASTIC DISORDERSКОМПЛЕКСНАЯ РЕАБИЛИТАЦИЯ ПАЦИЕНТОВ С ПОСТИНСУЛЬТНОЙ СПАСТИЧНОСТЬЮ НИЖНЕЙ КОНЕЧНОСТИ ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ БОТУЛОТОКСИНА (ОНАБОТУЛОТОКСИН А*)COMPLEX REHABILITATION PATIENTS WITH POST-STROKE SPASTICITY OF THE LOWER LIMB: THE EFFICACY OF BOTULINUM TOXIN (ONABOTULINUMTOXIN A)КОСТЕНКОЕ. В.KOSTENKOE. V.

д.м.н.

MD

ПЕТРОВАЛ. В.PETROVAL. V.

к.м.н.

PhD in medicine

Российский национальный исследовательский медицинский университет им. Н.И. Пирогова, Москва Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медициныРоссияPirogov Russian National Research Medical University, Moscow, Pirogow City Clinical Hospital; Moscow Centre for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine of Moscow Healthcare DepartmentRussian FederationМосковский научно-практический центр медицинской реабилитации, восстановительной и спортивной медициныРоссияMoscow Centre for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine of Moscow Healthcare DepartmentRussian Federation2016301220160119299Copyright © КОСТЕНКО Е.В., ПЕТРОВА Л.В., 20162016КОСТЕНКО Е.В., ПЕТРОВА Л.В.KOSTENKO E.V., PETROVA L.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1548

Цель исследования – изучение эффективности применения препарата онаботулотоксин А (Ботокс®) в комплексной реабилитации больных со спастичностью ноги в раннем восстановительном периоде инсульта. Материал и методы: группу наблюдения составили 31 пациент в раннем восстановительном периоде инсульта с эквиноварусной деформацией стопы с уровнем спастичности не менее 3 баллов. Все пациенты получали в составе комплексной реабилитационной программы инъекции онаботулотоксина А в общей дозе 300 ЕД. Оценивали динамику неврологического статуса, спастичности, болевого синдрома, функцию ходьбы и повседневную активность. Результаты и заключение: доказана высокая эффективность Ботокса в виде уменьшения выраженности спастичности, дискомфорта в голени и стопе, облегчения возможности самостоятельного передвижения больного, увеличения скорости ходьбы.

The purpose of the study was to examine the effectiveness of the drug of onabotulinumtoxin A (Botox) in complex rehabilitation of patients with post-stroke spasticity of the legs in the early rehabilitation period of stroke. Materials and methods. The study group was comprised 31 patients in the early recovery period after stroke with the presence of equino-varus deformity of the foot with the level of spasticity grade of 3 or more (MAS). All patients received as part of a comprehensive rehabilitation program injections onabotulinumtoxin a (Botox) in a total dose 300 ED. In the process of treatment was evaluated dynamics of neurological status, spasticity, pain, function of walking and everyday activity. Results and conclusion. Proven high efficacy of botulinum neurotoxin type A: reduces the severity of spasticity, the severity of the discomfort in the leg and foot; facilitated the possibility of independent movement of the patient, increases walking speed.

реабилитацияпостинсультная спастичностьинсультэквиноварусная деформация стопыrehabilitationpost-stroke spasticitystrokeequino-varus foot deformityReferencesWissel J, Manack A , Brainin M. Toward an epidemiology of poststroke spasticity. Neurology, 2013, 3(2): 13-19.Wissel J, Manack A , Brainin M. Toward an epidemiology of poststroke spasticity. Neurology, 2013, 3(2): 13-19.Феррахов А.З., Хабиров Ф.А., Ибрагимов М.Ф., Хай буллин Т.И., Гранатов Е.В. Комплексная реабилитация больных, перенесших инсульт, на этапах «стационар – реабилитационный центр – поликлиника». Неврологический вестник, 2012, 44(4): 3-8. [Ferrakhov A.Z., Khabirov F.A., Ibragimov M.F., Khaibullin T.I., Granatov E.V. Complex rehabilitation of patients who suffered from a str oke, at the stages “inpatient department – rehabilitation center – polyclinic”. Nevrologicheskiy Vestnik, 2012, 44 (4): 3-8].Феррахов А.З., Хабиров Ф.А., Ибрагимов М.Ф., Хай буллин Т.И., Гранатов Е.В. Комплексная реабилитация больных, перенесших инсульт, на этапах «стационар – реабилитационный центр – поликлиника». Неврологический вестник, 2012, 44(4): 3-8. [Ferrakhov A.Z., Khabirov F.A., Ibragimov M.F., Khaibullin T.I., Granatov E.V. Complex rehabilitation of patients who suffered from a str oke, at the stages “inpatient department – rehabilitation center – polyclinic”. Nevrologicheskiy Vestnik, 2012, 44 (4): 3-8].Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, et al. Use of botulinumtoxin type A in management of adult spasticity-a European consensus st atement. J Rehabil Med, 2003, 35: 98-99.Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, et al. Use of botulinumtoxin type A in management of adult spasticity-a European consensus st atement. J Rehabil Med, 2003, 35: 98-99.Парфенов В .А. Постинсультная спастичность и ее лечение. РМЖ, 2006, 1, 9(261): 689-693.Парфенов В .А. Постинсультная спастичность и ее лечение. РМЖ, 2006, 1, 9(261): 689-693.Urban P, Wolf T, Uebele M. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke, 2010, 41(9): 2016-2020.Urban P, Wolf T, Uebele M. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke, 2010, 41(9): 2016-2020.Picelli A, Tamburin S, Gajofatto F, Zanette G, Praitano M, Saltuari L et al. Association between Severe Upper Limb Spasticityand Brain Lesion Location in Stroke Patients. Biomed Research International, 2014, 1-6.Picelli A, Tamburin S, Gajofatto F, Zanette G, Praitano M, Saltuari L et al. Association between Severe Upper Limb Spasticityand Brain Lesion Location in Stroke Patients. Biomed Research International, 2014, 1-6.Reichel G. Therapielietfa den Spastik. 3. Auflage-Bremen, UNI-MED, 2013: 190.Reichel G. Therapielietfa den Spastik. 3. Auflage-Bremen, UNI-MED, 2013: 190.Watkins C, Leathley M, Gregson J, Moore A, Smith T, Sharma A. Prevalence of spasticity post stroke. Clinical Rehabil, 2002, 16: 515-552.Watkins C, Leathley M, Gregson J, Moore A, Smith T, Sharma A. Prevalence of spasticity post stroke. Clinical Rehabil, 2002, 16: 515-552.Lundström E, Smits A, Borg J, Terént A. C omment in Stroke, 2010, 41(7): e470, author reply e471. Stroke, 2010, 41(2): 201-202.Lundström E, Smits A, Borg J, Terént A. C omment in Stroke, 2010, 41(7): e470, author reply e471. Stroke, 2010, 41(2): 201-202.Батышева Т.Т., Бойко А.Н., Костенко Е.В. Методологические основы лечения спастичности. Медико-социальные аспекты лечения спастичн ости в практике врача-невролога. Материалы научно-практической конференции. М., 2010: 6-9. [Batysheva T.T., Boyko A.N., Kostenko E.V. Methodological fundamentals of spacticity therapy. Medical and social aspects of spasticity therapy in the practice of a neurologist. Materials of scientific and practical conference. M., 2010; 6-9].Батышева Т.Т., Бойко А.Н., Костенко Е.В. Методологические основы лечения спастичности. Медико-социальные аспекты лечения спастичн ости в практике врача-невролога. Материалы научно-практической конференции. М., 2010: 6-9. [Batysheva T.T., Boyko A.N., Kostenko E.V. Methodological fundamentals of spacticity therapy. Medical and social aspects of spasticity therapy in the practice of a neurologist. Materials of scientific and practical conference. M., 2010; 6-9].Гусев Е.И., Гехт А.Б., Гаптов В.Б., Тихопой Е.В. Реабилитация в неврологии. М., 2000: 52. [ Gusev E.I., Gekht A.B., Gaptov V.B., Tikhopoy E.V. Rehabilitation in neurology. M., 2000: 52].Гусев Е.И., Гехт А.Б., Гаптов В.Б., Тихопой Е.В. Реабилитация в неврологии. М., 2000: 52. [ Gusev E.I., Gekht A.B., Gaptov V.B., Tikhopoy E.V. Rehabilitation in neurology. M., 2000: 52].Воробьева О.В. Нарушение мышечного тонуса в постинсультном периоде: вопросы терапии. Consilium Medicum, 2004, 6: 12-18. [ Vorobieva O.V. Disturbance of muscular tonus in poststroke period: issues of therapy. Consilium Medicum, 2004, 6: 12-18].Воробьева О.В. Нарушение мышечного тонуса в постинсультном периоде: вопросы терапии. Consilium Medicum, 2004, 6: 12-18. [ Vorobieva O.V. Disturbance of muscular tonus in poststroke period: issues of therapy. Consilium Medicum, 2004, 6: 12-18].Хатькова С.Е. Лечение спастичности после инсульта. Неврология, нейропсихиатрия, психосоматика, 2010, 3: 76-80. [Khatkova S.E. Treatment of spasticity after stroke. Nevrologia, neuropsikhiatria, psikhosomatika, 2010, 3: 76-80].Хатькова С.Е. Лечение спастичности после инсульта. Неврология, нейропсихиатрия, психосоматика, 2010, 3: 76-80. [Khatkova S.E. Treatment of spasticity after stroke. Nevrologia, neuropsikhiatria, psikhosomatika, 2010, 3: 76-80].Pathak M, Nguyen H, Graham H, Moore A. Management of spasticity in adults: practical application of botulinumtoxin. Eur J. Neurol, 2006, 13: 42-50.Pathak M, Nguyen H, Graham H, Moore A. Management of spasticity in adults: practical application of botulinumtoxin. Eur J. Neurol, 2006, 13: 42-50.Gracies JM., Singer BJ, Dunne JW. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Disabil Rehabil, 2007, 29(23): 1789-1803.Gracies JM., Singer BJ, Dunne JW. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Disabil Rehabil, 2007, 29(23): 1789-1803.Kirazli Y, On A.Y, Kismali B, Aksit R. Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil, 1998, 77: 510-515.Kirazli Y, On A.Y, Kismali B, Aksit R. Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil, 1998, 77: 510-515.Suputtitada A, Suwanwela N. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticit y. Disabil Rehabil, 2005, 27: 176-184.Suputtitada A, Suwanwela N. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticit y. Disabil Rehabil, 2005, 27: 176-184.Малахов В.А. Мышечная спастичность при органических заболеваниях нервной системы и ее коррекция. Международный неврологический журнал, 2010, 5(35): 34-39. [Malakhov V.A. Muscular spasticity in organic diseases of the nervous system and its correction. Mezhdunarodny Nevrologichesky J ournal, 2010, 5 (35): 34-39].Малахов В.А. Мышечная спастичность при органических заболеваниях нервной системы и ее коррекция. Международный неврологический журнал, 2010, 5(35): 34-39. [Malakhov V.A. Muscular spasticity in organic diseases of the nervous system and its correction. Mezhdunarodny Nevrologichesky J ournal, 2010, 5 (35): 34-39].Dressler D, AdibSaberi F. Botulinumtoxin: mechanismsofaction. Eur Neurol, 2005, 53: 3-9.Dressler D, AdibSaberi F. Botulinumtoxin: mechanismsofaction. Eur Neurol, 2005, 53: 3-9.Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. MovDisord, 2009, 24(6): 801-812.Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. MovDisord, 2009, 24(6): 801-812.Gallichio JE Pharmacologic management of spasticity following stroke. Phys Ther, 2004, 84(10): 973-981.Gallichio JE Pharmacologic management of spasticity following stroke. Phys Ther, 2004, 84(10): 973-981.Guidelines for the use of botulinum toxin (BTX) in the management of spasticity in adults. Clinical Effectiveness & Evaluation, Unit. Royal College of Physicians, 2002, 17.Guidelines for the use of botulinum toxin (BTX) in the management of spasticity in adults. Clinical Effectiveness & Evaluation, Unit. Royal College of Physicians, 2002, 17.Johnson C, Burridge J, Strike P, Wood D, Swain I. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Arch Phys Med Rehabil, 2004, 85: 9 02-909.Johnson C, Burridge J, Strike P, Wood D, Swain I. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Arch Phys Med Rehabil, 2004, 85: 9 02-909.O’Brien C. Treatment of spasticity with botulinum toxin. Clin J Pain, 2002, 18: 1 82-190.O’Brien C. Treatment of spasticity with botulinum toxin. Clin J Pain, 2002, 18: 1 82-190.Cheung J, Rancourt А, Di Poce S, Levine А, Hoang J, Ismail F. Patient-Identified Factors That Influence Spasticity in People with Stroke and Multiple Scler osis Receiving Botulinum Toxin Injection Treatments. Physiother Can, 2015, 67(2): 157-166.Cheung J, Rancourt А, Di Poce S, Levine А, Hoang J, Ismail F. Patient-Identified Factors That Influence Spasticity in People with Stroke and Multiple Scler osis Receiving Botulinum Toxin Injection Treatments. Physiother Can, 2015, 67(2): 157-166.Кадыков А.С.,Черникова Л.А., Шахпаронова Н.В. Реабилитация неврологических больных. М: МЕДпресс-информ, 2008: 560. [Kadykov A.S., Chernikova L.A., Shakhparanova N.V. Rehabilitaiton of neurologic patients. M: MEDpress-inform, 2008:560].Кадыков А.С.,Черникова Л.А., Шахпаронова Н.В. Реабилитация неврологических больных. М: МЕДпресс-информ, 2008: 560. [Kadykov A.S., Chernikova L.A., Shakhparanova N.V. Rehabilitaiton of neurologic patients. M: MEDpress-inform, 2008:560].Francis H, Wade D, Turner-Stokes L., Kingswell R, Dott C, Coxon E. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry, 2004, 75: 1547-1551.Francis H, Wade D, Turner-Stokes L., Kingswell R, Dott C, Coxon E. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry, 2004, 75: 1547-1551.Turkel C, Bowen B, Liu J, Brin M. Pooled analysis of the safety of botulinum toxin type Ain the treatment of post-stroke spasticity. Arch Phys Med Rehabil, 2006, 87: 786-792.Turkel C, Bowen B, Liu J, Brin M. Pooled analysis of the safety of botulinum toxin type Ain the treatment of post-stroke spasticity. Arch Phys Med Rehabil, 2006, 87: 786-792.Bakheit A, Fedorova N, Skoromets A, Timerbaeva S, Bhakta B, Coxon L. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry, 2004, 75: 1558-1561.Bakheit A, Fedorova N, Skoromets A, Timerbaeva S, Bhakta B, Coxon L. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry, 2004, 75: 1558-1561.Brashear A, Gordon M, Elovic E, Kassicieh V, Marciniak C, Do M., Botox Post-Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med, 2002, 347: 395-400.Brashear A, Gordon M, Elovic E, Kassicieh V, Marciniak C, Do M., Botox Post-Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med, 2002, 347: 395-400.Opheim А, Danielsson А, Alt Murphy М, Persson Н, Sunnerhagen К. Early prediction of longterm upper limb spasticity after stroke: Part of the SALGOT study. Neurology, 2015, 85(10): 873-880.Opheim А, Danielsson А, Alt Murphy М, Persson Н, Sunnerhagen К. Early prediction of longterm upper limb spasticity after stroke: Part of the SALGOT study. Neurology, 2015, 85(10): 873-880.Burbaud P, Wiart L, Dubos J, Gaujard E, Debelleix X, Joseph P. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry, 1996, 61: 265-269.Burbaud P, Wiart L, Dubos J, Gaujard E, Debelleix X, Joseph P. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry, 1996, 61: 265-269.Childers M, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. ArchPhys Med Rehabil, 2004, 85: 1063-1069.Childers M, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. ArchPhys Med Rehabil, 2004, 85: 1063-1069.Gordon M, Brashear A, Elovic E, Kassicieh D, Marciniak C. Botox Post-Stroke Spasticity Study Group. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Neurology, 2004, 63: 1 971-1973.Gordon M, Brashear A, Elovic E, Kassicieh D, Marciniak C. Botox Post-Stroke Spasticity Study Group. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Neurology, 2004, 63: 1 971-1973.Hesse S, Reiter F, Konrad M, Jahnke M. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-b lind, placebo-controlled trial. Clin Rehabil, 1998, 12: 381-388.Hesse S, Reiter F, Konrad M, Jahnke M. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-b lind, placebo-controlled trial. Clin Rehabil, 1998, 12: 381-388.Pandyan A, Vuadens P, van Wijck F, Stark S, Johnson G, Barnes M. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Clin Rehabil, 2002, 16: 654-660.Pandyan A, Vuadens P, van Wijck F, Stark S, Johnson G, Barnes M. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Clin Rehabil, 2002, 16: 654-660.Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol, 2002, 249: 76-84.Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol, 2002, 249: 76-84.Ryuji K, Yuka O, Kazuaki S, Toshio M, Yasuyuki U. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial . J Neurol, 2008, 257: 1330-1337.Ryuji K, Yuka O, Kazuaki S, Toshio M, Yasuyuki U. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial . J Neurol, 2008, 257: 1330-1337.Bayram S, Sivrioglu K, Karli N, Ozcan O. Lowdose botulinum toxin with short-term electrical stimulation in post-stroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil, 2006, 85: 75-81.Bayram S, Sivrioglu K, Karli N, Ozcan O. Lowdose botulinum toxin with short-term electrical stimulation in post-stroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil, 2006, 85: 75-81.Dengler R, NeyerU, Wohlfarth K, Bettig U., Janzik H. Local botulinum toxin in the treatment of spastic drop foot. J Neurol, 1992, 239: 375-378.Dengler R, NeyerU, Wohlfarth K, Bettig U., Janzik H. Local botulinum toxin in the treatment of spastic drop foot. J Neurol, 1992, 239: 375-378.Ward A. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol, 2012, 19: 21-27.Ward A. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol, 2012, 19: 21-27.Hesse S, Jahnke M, Luecke D, Mauritz K. Shortterm electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett, 1995, 201: 37 -40.Hesse S, Jahnke M, Luecke D, Mauritz K. Shortterm electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett, 1995, 201: 37 -40.Pittock S, Moore A, Hardiman O. A double-blindrandomized placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport). J Neurol Neurosurg Psychiatry, 1999, 58: 1345-1349.Pittock S, Moore A, Hardiman O. A double-blindrandomized placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport). J Neurol Neurosurg Psychiatry, 1999, 58: 1345-1349.Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment. Brain Inj, 2013, 27: 1093-1105.Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment. Brain Inj, 2013, 27: 1093-1105.Opheim A, Danielsson A, Alt Murphy M, Persson HC, Sunnerhagen K. Upper limb spasticity during the first year after stroke: a longitudinal study at the University of Gothenburg (SALGOT ). Am J Phys Med Rehabil, 2014, 93: 884-896.Opheim A, Danielsson A, Alt Murphy M, Persson HC, Sunnerhagen K. Upper limb spasticity during the first year after stroke: a longitudinal study at the University of Gothenburg (SALGOT ). Am J Phys Med Rehabil, 2014, 93: 884-896.Костенко Е.В., Петрова Л.В., Ганжула П.Н., Хозова А.А., Бойко А.Н. Опыт применения ксеомина в коррекции спастичности руки в ранний восстановительный период инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова, 2012, 112, 2: 29-3. [Kostenko E.V., Petrova L.V., Ganzhula P.N., Khozova A.A. , Boyko A.N. Experience of xeomin use for correction of hand spasticity at an early rehabilitation period after stroke. Zhurnal Nevrologii I Psikhiatrii im. S.S. Korsakova, 2012, 112, 2:29-3]Костенко Е.В., Петрова Л.В., Ганжула П.Н., Хозова А.А., Бойко А.Н. Опыт применения ксеомина в коррекции спастичности руки в ранний восстановительный период инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова, 2012, 112, 2: 29-3. [Kostenko E.V., Petrova L.V., Ganzhula P.N., Khozova A.A. , Boyko A.N. Experience of xeomin use for correction of hand spasticity at an early rehabilitation period after stroke. Zhurnal Nevrologii I Psikhiatrii im. S.S. Korsakova, 2012, 112, 2:29-3]

The authors declare that there are no conflicts of interest present.